Brief: CorMedix Reports First Quarter 2023 Financial Results
May 15 (Reuters) - CorMedix Inc CRMD.O :
* CORMEDIX INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* CORMEDIX INC Q1 LOSS PER SHARE $0.24
* CORMEDIX INC - BELIEVES THAT IT HAS SUFFICIENT RESOURCES
TO FUND
OPERATIONS AT LEAST THROUGH FIRST HALF OF 2024
Source text for Eikon: ID:nGNX7M9jVL
Further company coverage: CRMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CorMedix
See all newsBrief: Cormedix Announces FDA Acceptance For Priority Review Of Supplemental NDA For Rezzayo
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
CorMedix Inc. reports results for the quarter ended June 30 - Earnings Summary